Gliquidone

This classification denotes an anti-diabetic agent with the molecular formula C27H33N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) C7C2QDD75P, chemically known as 1-cyclohexyl-3-(p-beta-(4,4-dimethyl-2-methoxy-1,3-(2h,4h)-isoquinolinedione-2-yl)phenethyl)sulfonylurea but more generally known as gliquidone, which bears US NIH Compound Identifier 91610. European Medicines Agency schedules Gliquidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07928MIG. The term GLIQUIDONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, No. 10 1973, List 13) WHO schedules gliquidone in its Anatomical Therapeutic Chemical (ATC) Classification. GLIQUIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule gliquidone under HS 29350090 and SITC 51580. As of Q4 2014, GLIQUIDONE remains US FDA's Preferred Term for this commodity. Gliquidone bears US NLM identifiers UMLS ID C0061328 and NCI Concept Code C72798. SMILES: S(=O)(=O)(NC(=O)NC1CCCCC1)C1CCC(CCN2C(=O)C(C3C(C2=O)CC(OC)CC3)(C)C)CC1.